2) Targeted Active-Site Peptide MS Method Development and Acquisition
ProbeµéÀ» ÀÌ¿ëÇÏ¿© ³óÈÄÈµÈ ½Ã·á¿¡¼ Ȱ¼ºÈ¿¼ÒÀÇ È°¼ºÀÚ¸®¿¡ ´ëÇÑ ÆéŸÀ̵åÀÇ »ó´ëÀûÀÎ ¾çÀ» Pinpoint Software ÀÌ¿ëÇØ ÆéŸÀÌµå ½ÅÈ£µéÀÇ ³ÐÀº Dynamic Range¸¦ ¹àÇô³Â´Ù. ´õ dzºÎÇÑ È°¼ºÀÚ¸® ÆéŸÀ̵åµéÀº HR/AM Full-Scan MS¸¦ »ç¿ëÇÏ¿© Á¤·®ÇÏ¿´´Ù. ±Ø¹Ì·®ÀÇ Intensity°¡ ³·Àº ÆéŸÀ̵åµéÀº ÆéŸÀ̵å ÀÌ¿ÂÀÇ Signal Intensity¸¦ Çâ»ó½Ã۱â À§ÇØ Multiplexed SIM (msxSIM)·Î ¼±º°µÇ¾ú´Ù. Q Exactive Áú·®ºÐ¼®±âÀÇ ÁÖ¿äÇÑ ÀåÁ¡Àº Orbitrap¿¡¼ÀÇ ÀÌ¿ÂÀ» °ËÃâÇÏ´Â µ¿¾È ÀÌ¿ÂÀÇ C-trapingÀÌ µ¿½Ã¿¡ °¡´ÉÇÏ´Ù´Â °ÍÀÌ´Ù(Figure 4A & B). ÀÌ ±â´ÉÀ¸·Î ¼±ÅÃµÈ À̿µéÀÌ °¡µÎ¾îÁü°ú µ¿½Ã¿¡ °ËÃâÇÔÀ¸·Î½á Cycle½Ã°£À» Å©°Ô ÁÙÀÌ°Ô µÈ´Ù. ÀÌ ÀåÁ¡Àº Targeted Multiplexed SIM°¡ ¿¹Á¤µÇ¾úÀ» ¶§, ´ÙÁßÀÇ Targeted À̿µéÀ» µ¿½Ã¿¡ °¡µÒÀ¸·Î½á ´õ¿í ¹è°¡µÈ´Ù. OrbitrapÀÌ °ËÃâÇÏ´Â µ¿¾È, C-trapÀº ¼øÂ÷ÀûÀ¸·Î Á¼Àº Áú·® ¹üÀ§·Î Á¤ÀÇµÈ À̿µé·Î ä¿öÁø´Ù. º» ½ÇÇèÀº ÃÖ´ë 4°³ÀÇ Mass Windows ±îÁö·Î MultiplexingÀ» Á¦ÇÑÇÏ¿´Áö¸¸, MS Method»ó¿¡¼´Â 10°³ Áú·® ¹üÀ§±îÁö ÀÌ¿ÂÀ» ¸ð¾Æ µ¿½Ã¿¡ ºÐ¼®ÇÏ´Â °ÍÀÌ °¡´ÉÇÏ´Ù. Full-Scan MS¿Í msxSIM »çÀÌÀÇ CyclingÀº Target SelectivityÀ» À¯ÁöÇϴµ¥ »ç¿ëµÈ´Ù. Full-Scan MS¿Í msxSIM »çÀÌÀÇ ±³È¯°ú °°Àº ÀÌ·¯ÇÑ Á¢±Ù ¹æ¹ýÀº ULK3 Ȱ¼ºÈ¿¼Ò Ȱ¼º ÀÚ¸® ÆéŸÀ̵åÀÎ NISHLDLKPQNILLSSLEKPHLKÀÇ Targeted ºÐ¼®¿¡ ÀÀ¿ëµÇ¾ú´Ù(Figure 4C). 1.2ÃÊ µ¿¾È Full-Scan°ú SIM ¸ðµå·Î ¾ò¾îÁø ¸ðµç µ¥ÀÌÅ͵éÀº Á¼Àº ¹üÀ§ÀÇ Retention timeÀÌ Centroid ¸ðµå¿¡¼ º¸¿©Áø´Ù. Full Scan ¸ðµå¿¡¼ÀÇ XIC(Extracted ion chromatogram) ±¸¼ºÀ» º¸¸é ±5 ppmÀÇ Mass Tolerance¸¦ »ç¿ëÇÏ¿© ÇÊÅ͸µÇßÀ½¿¡µµ ºÒ±¸ÇÏ°í ¸¹Àº ¼öÀÇ ÇÇÅ©µéÀ» º¼ ¼ö ÀÖ´Ù. ÀÌ °Á¶µÈ ºÎºÐÀº Base PeakÀÇ Intensity°¡ ´ÜÁö 3%¿´À½¿¡µµ Targeted Ȱ¼º ÀÚ¸® ÆéŸÀ̵忡 ´ëÇÑ ¿¹»óµÇ´Â ¿ëÃ⠽ð£À» Æ÷ÇÔÇϰí ÀÖ´Ù. XIC ProfileÀº SIM event¿¡ ´ëÇÑ ¿¹Á¤µÈ Targeted µ¥ÀÌÅÍ È¹µæ ¹æ¹ýÀÌ °£¼·¾øÀÌ ºÐ¸íÇÏ°Ô °ü½É¹°ÁúÀÇ ÇÇÅ©¸¦ ÃøÁ¤ÇÑ´Ù´Â °ÍÀ» º¸¿©ÁØ´Ù. SIM event¸¦ ´ÙÁßÈ(Multiplexing)ÇÔÀ¸·Î½á, ULK3 ´Ü¹éÁúÀÇ È°¼ººÎÀ§ ÆéŸÀ̵å¿Í µ¿ÀÏÇÑ Retention Tme¿¡¼ µ¿½Ã¿¡ ºÐ¸®µÈ, 2°³ÀÇ Ãß°¡ Ȱ¼º ºÎÀ§ ÆéŸÀ̵åÀÇ ¼±ÅÃÀûÀÎ µ¥ÀÌÅÍ È¹µæÀ» ¿ëÀÌÇÏ°Ô ¿´´Ù. Full-scan MS scan¿¡¼ÀÇ ¸¹Àº ¼öÀÇ ¹é±×¶ó¿îµå À̿¿¡µµ ºÒ±¸Çϰí 3°³ÀÇ Target m/z°ªÀ» msxSIM Window¿¡¼ ½±°Ô ȹµæÇÒ ¼ö ÀÖ¾ú´Ù. SIM eventÀÇ ´ÙÁßÈ´Â ULK3 Ȱ¼ºÀÚ¸® ÆéŸÀ̵åÀÇ µ¿ÀÏÇÑ Retention Time Window¿¡¼ µ¿½Ã¿¡ ºÐ¸®µÇ´Â (Co-eluted) µÎ °³ÀÇ Ãß°¡ Ȱ¼ºÀÚ¸® ÆéŸÀ̵忡 ´ëÇÑ ¼±ÅÃÀûÀÎ µ¥ÀÌÅÍ È¹µæÀ» ¿ëÀÌÇÏ°Ô ÇÑ´Ù(Figure 5A).

Figure 4. The Q Exactive mass spectrometer (A) is capable of multiple C-trap filling during Orbitrap detection (B) and producing a multiplexed spectrum (C).
Full-scan MS scan¿¡¼ º¸¿©Áö´Â ¸¹Àº ¼öÀÇ Background À̿µ鿡µµ ºÒ±¸Çϰí 3°³ÀÇ Target m/z°ªÀ» msxSIM Window¿¡¼ ½±°Ô ȹµæµÈ´Ù. Target m/z°ª¿¡ ±Ù»çÇÑ m/z°ªÀ» °¡Áø ÀÌ¿ÂÀ» Quadrupole Mass FilteringÇÔÀ¸·Î½á, Target ÆéŸÀ̵å Precursor IonÀÇ ´õ ¸¹Àº ÃàÀûÀ» °¡´ÉÇÏ°Ô ÇÏ¿´´Ù. Figure 5B´Â Full-Scan MS, SIM, ÀÌ·ÐÀûÀÎ Isotopic ºÐÆ÷¿¡¼ Á¼Àº Áú·®¹üÀ§ÀÇ Á߽ɿ¡ ÀÖ´Â NISHLDLKPQNILLSSLEKPHLK +4 PrecursorÀÇ m/z °ªÀ» º¸¿©ÁØ´Ù. Full MS Scan¿Í SIM Scan ¸ðµÎ¿¡¼ ÀÌ ÆéŸÀ̵å¿Í µ¿½Ã¿¡ ºÐ¸®µÈ +3 Charge StateÀÇ ¸ÅÆ®¸¯½º ÀÌ¿ÂÀ» È®ÀÎÇß´Ù. ±×·¯³ª, °íÇØ»óµµÀÇ Orbitrap Áú·®ºÐ¼®±â´Â 20%ÀÇ »ó´ëÀûÀÎ Intensity¿¡¼ Matrix Ion°ú A+2 Target IsotopeÀÇ Áú·® Â÷°¡ ´ÜÁö 0.05 Da (76 ppm)ÀÏÁö¶óµµ Background ½ÅÈ£µé·ÎºÎÅÍÀÇ ºÐ¸®¸¦ ¿ëÀÌÇÏ°Ô ÇÑ´Ù. SIM event ¿ª½Ã Full-scan MS¿Í ºñ±³ÇÏ¿© Target ÆéŸÀÌµå µ¿À§¿ø¼Òµé¿¡ ´ëÇÏ¿© Áõ°¡µÈ ½ÅÈ£µé°ú ´õ Á¤±³ÇÑ ±¸Á¶¸¦ Á¦°øÇÑ´Ù. °¢ ÆéŸÀ̵åµéÀº µ¶¸³µÈ Target MS2 ½ÇÇèÀ» ÅëÇØ ºÐ¼®ÇÏ¿´´Ù. Target msxSIM°ú Target MS2 ½ÇÇè¿¡¼ ¶Ù¾î³ Retention Time »ó°ü°ü°è°¡ °üÂûµÇ¾ú´Ù(µ¥ÀÌÅÍ Ã·ºÎ »ý·«).
HR/AM MS Data (Full–Scan°ú msxSIM Data)¸¦ »ç¿ëÇÑ µ¥ÀÌÅÍ È¹µæ ÈÄ È®ÀÎ, ÅëÇÕ ±×¸®°í »ó´ëÀûÀÎ Á¤·®ºÐ¼®Àº Pinpoint Software¸¦ »ç¿ëÇÏ¿© ¼öÇàµÇ¾ú´Ù. Figure 6AÀº °³º°ÀûÀÎ Isotopic XICµé(Centroid Mode¿¡¼ º¸¿©Áö´Â)°ú ÃøÁ¤µÈ AUC °ªµéÀ» º¸¿©ÁØ´Ù. msxSIM event¿¡¼ºÎÅÍ Full-scan MS ȹµæ ±×¸®°í msxSIM Àç °ËÃâ±îÁöÀÇ CycleÀ» À§Çؼ´Â ÃÑ 1.8Ãʰ¡ ÇÊ¿äÇÏ¸ç ±× °á°ú·Î Àüü ¿ëÃâµÈ ÇÇÅ©¿¡ °ÉÃÄ 12°³ÀÇ ScanµéÀ» ¾ò¾ú´Ù. Charge State¸¶´Ù 4°³ÀÇ °¡Àå dzºÎÇÑ Isotopeµé¿¡ ´ëÇÑ ÀÌ·ÐÀûÀÎ m/z °ªÀ» °è»êÇϱâ À§ÇØ »ç¿ëÀÚ°¡ Á¤ÀÇÇÑ Sequence¿Í º¯ÇüµéÀÌ »ç¿ëµÇ¾ú´Ù. Full MS¿Í msxSIM ScanµéÀ» À§ÇØ ±5 ppmÀÇ XIC Extraction Tolerance°¡ »ç¿ëµÇ¾ú´Ù. °á°úÀûÀ¸·Î, µ¶¸³ÀûÀ¸·Î ¼öÇàµÇ¾îÁø °¢°¢ÀÇ IsotopicµéÀº ±×·ìÈµÇ°í ±×·± ´ÙÀ½ »óÀÀÇÏ´Â Isotopeµé°ú ¸ðµç Precursor Charge StatesÀÇ Retention Time¿¡ ´ëÇÑ Target ÆéŸÀ̵åµéÀ» ºÐ¼®Çϰí È®ÀÎÇϱâ À§ÇØ °ãÃÄÁø´Ù(Figure 6B).
°í ºÐÇØ´É°ú Á¤È®¼ºÀº Full-scan MS¿Í msxSIM MSºÐ¼®¿¡¼ ¼±ÅÃÀûÀ¸·Î Target ÀÌ¿ÂÀ» À¯ÁöÇϱâ À§ÇØ ¶ÇÇÑ »ç¿ëµÈ´Ù. Pinpoint Software´Â Isotopic XIC¸¶´Ù ÀáÀçÀûÀÎ Background °£¼·À» ¹àÈú ¼ö ÀÖ´Ù. Figure 6C´Â NISHLDLKPQNILLSSLEKPHLK ÆéŸÀ̵åÀÇ +4 ±×¸®°í +5 Precursor Charge States¿¡ ´ëÇÑ ½ÇÇèÀûÀÎ °ª°ú ÀÌ·ÐÀûÀÎ °ªµé »çÀÌ¿¡¼ÀÇ Isotopic ºÐÆ÷ÀÇ °ãÃÄÁüÀ» º¸¿©ÁØ´Ù. Charge States¿¡ ´ëÇÑ ³»Àû »ó°ü°è¼ö(Dot-Product Correlation Coefficients)´Â °¢°¢ 0.95¿Í 0.98ÀÌ´Ù. ÀϰüµÈ ÇÇÅ© ¸ð¾ç°ú »ó´ëÀûÀÎ Isotopic ºÐÆ÷´Â ¸ÅÆ®¸¯½º Background°¡ ¾Æ´Ñ Target ÆéŸÀ̵忡¼ ±âÀÎÇÑ ÃøÁ¤µÈ ½ÅÈ£µé¿¡ ´ëÇÑ ½Å·Úµµ¸¦ Áõ°¡½ÃŲ´Ù. Figure 6D´Â ¸ðµç »ý¹°ÇÐÀû »óŵé°ú ¹Ýº¹½ÇÇè¿¡ ´ëÇÑ +4 Charge State¿¡ °üÇÏ¿© ÅëÇÕµÈ È÷½ºÅä±×·¥ÀÌ´Ù. °è»êµÈ »ó°ü°è¼ö(Correlation Coefficients)´Â ¸ðµç ÆÄÀÏ¿¡¼ 0.95 ÀÌ»óÀ̾ú°í, ÀÌ´Â ¿ÜºÎÀûÀ¸·Î º¸Á¤µÈ Áú·®ÀÇ Á¤È®µµ°¡ »ùÇÃÀ» ºÐ¼®ÇÏ´Â µ¿¾È À¯ÁöµÇ¾ú´Ù´Â °ÍÀ» °¡¸®Å²´Ù.
3) Kinase Inhibitor Profiling and IC50 Determination
Full-scan MS¿Í ¾Õ¼ ¼¼úÇÑ msxSIM ¹æ¹ýÀ» ÅëÇÕÇØ »ç¿ëÇϸé, ´ÙÁßÀÇ »ùÇÃµé ¶Ç´Â Ã³¸® Á¶°Ç¿¡ µû¶ó ¹ßÇöÇÑ È°¼ºÈ¿¼ÒÀÇ »ó´ëÀûÀÎ ¾çÀÌ ²ÙÁØÈ÷ Æò°¡µÉ ¼ö ÀÖ´Ù. Ȱ¼ºÈ¿¼Ò ¾ïÁ¦Á¦ ProfilingÀº ¾à¹° ó¸® Àü°ú ÈÄ¿¡ Ȱ¼ºÈ¿¼Ò Ȱ¼ºÀÚ¸® ÆéŸÀ̵åÀÇ »ó´ëÀûÀÎ ¾çÀÇ º¯È¸¦ ÃøÁ¤ÇÔÀ¸·Î½á È¿°úÀûÀÎ ½ÇÇè¹æ¹ýÀ¸·Î Æò°¡µÉ ¼ö ÀÖ´Ù. ¾ïÁ¦Á¦ °áÇÕ Ä£Èµµ ¶ÇÇÑ ¿ë·® ¹ÝÀÀ °î¼±(Dose Response Curve)À¸·ÎºÎÅÍ IC50 °ªÀ» °áÁ¤Çϱâ À§ÇØ ¾ïÁ¦Á¦ÀÇ ³óµµ¸¦ ÀûÁ¤ÇÔÀ¸·Î½á È®À뵃 ¼ö ÀÖ´Ù. ¾ïÁ¦Á¦ÀÇ ³óµµ°¡ Áõ°¡ÇÒ ¶§ ¾ïÁ¦µÈ Ȱ¼ºÈ¿¼Ò ÆéŸÀ̵åÀÇ ½ÅÈ£°¡ °¨¼ÒµÇ±â ¶§¹®¿¡ Targeted msxSIM ȹµæ ¹æ¹ýÀº ÀÌ·± ¿¬±¸¿¡ ȹ±âÀûÀÎ ºÐ¼®¹æ¹ýÀÌ µÈ´Ù.
Figure 7Àº ±¤¹üÀ§ÇÑ Æ¯À̼ºÀ» °¡Áø Ȱ¼ºÈ¿¼Ò ¾ïÁ¦Á¦ÀÎ StaurosporineÀÇ ¾çÀ» Áõ°¡ÇÏ¿© ó¸®ÇÑ »ùÇÃÀ» msxSIM ¹æ¹ýÀ¸·Î ó¸®ÇÏ¿© ÃøÁ¤ÇÑ µ¿½Ã¿¡ ºÐ¸®µÈ 3°³ÀÇ È°¼º ÀÚ¸® ÆéŸÀ̵带 »ó´ëÀûÀ¸·Î Á¤·® ºÐ¼®ÇÑ °ÍÀ» º¸¿©ÁØ´Ù. Figure 7A´Â µÎ ¹øÀÇ ±â¼úÀûÀÎ ¹Ýº¹ ½ÇÇè¿¡¼ »ùÇà ´ç °¢°¢ÀÇ Targeted ÆéŸÀ̵忡 ´ëÇÑ °ãÃÄÁø XICÀ» µµÇ¥ÈÇÑ °ÍÀ» º¸¿©ÁØ´Ù. GCK Ȱ¼ºÈ¿¼Ò(DTVTSELLAAVKIVK)¿Í ULK3 Ȱ¼ºÈ¿¼Ò (NISHLDLKPQNILLSSLEKPHLK)´Â ¸ðµÎ 0.1 mM ¹Ì¸¸ÀÇ StaurosporineÀ» ó¸®ÇÏ¿´À» ¶§ ÃæºÐÈ÷ ¾ïÁ¦¸¦ º¸ÀÎ ¹Ý¸é, PKR Ȱ¼ºÈ¿¼Ò(DLKPSNIFLVDTK)´Â StaurosporineÀ» 󸮿¡ ´ëÇÏ¿© ¹Ì¹ÌÇÑ ¾ïÁ¦¸¦ º¸ÀδÙ. ¿ë·® ¹ÝÀÀ °î¼±(Dose Response Curve)À» µµÇ¥ÈÇÏ°í °¢ Ȱ¼ºÈ¿¼Ò¿¡ ´ëÇÑ IC50 ¸¦ °è»êÇϴµ¥ »ó´ëÀûÀÎ ÆéŸÀÌµå ½ÅÈ£ Intensity°¡ »ç¿ëµÇ¾ú´Ù(Figure 7B). Staurosporine Ȱ¼ºÈ¿¼Ò ¾ïÁ¦ ProfilingÀ» À§ÇØ, Á¾ÇÕÀûÀÎ µ¥ÀÌÅͰ¡ ¸î¸î ´ëü ºÐ¼®¹æ¹ý¿¡¼ ¶ÇÇÑ »ç¿ëµÉ ¼ö ÀÖ°í, ±â ¿¬±¸µÈ °á°ú·ÎºÎÅÍ ¾ò¾îÁø °ªµé°ú ¸Å¿ì À¯»çÇÏ´Ù.

Figure 6. Data processing strategy using Pinpoint software for HR/AM MS and msxSIM data where (A) shows the individual isotopic XIC plots in centroid display mode, (B) shows an overlaid XIC plot for retention-time determination, (C) shows the isotopic distribution overlap between experimental and theoretical profiles for each charge state, and (D) shows the resulting isotopic distribution for all resulting RAW files acquired in the study.

Figure 7. Targeted msxSIM analysis for low-level co-eluting active-site peptides. Comparative overlaid XIC plot at each titrated staurosporine level (A). Dose-response curves of the measured peptide signal inhibition as a function of titrated staurosporine concentration with calculated IC50 values for each active-site peptide (B).
Table 3Àº StaurosporineÀ» ó¸®ÇÑ ÈÄ º» ¿¬±¸¹ý¿¡¼ Á¤·® ºÐ¼®ÇÑ ¸ðµç Ȱ¼ºÈ¿¼Ò¸¦ ³ª¿ÇÑ °ÍÀÌ´Ù. ó¸®ÇÑ Staurosporine(10 μM) »ùÇõéÀ» ó¸®ÇÏÁö ¾ÊÀº Staurosporine°ú »ó´ëÀûÀÎ Intensity¿Í ºñ±³ÇÔÀ¸·Î½á ±×µéÀÇ È°¼ºÈ¿¼ÒµéÀº ¾ïÁ¦ ÆÛ¼¾Æ®(%)¿¡ ÀÇÇØ ±×·ìȵǾú´Ù. ÀÌ ºÐ¼®Àº ¾î¶² Ȱ¼ºÈ¿¼Ò°¡ Staurosporine°ú °áÇÕÇÏ´ÂÁö ¸íÈ®ÇÏ°Ô º¸¿©ÁÖ°í °øÅëÀÇ ¾ïÁ¦¸¦ º¸À̴ Ȱ¼ºÈ¿¼ÒÀÇ ¾Æ°ú(Subfamily)¸¦ ºÐ¼®Çϱâ À§ÇØ »ç¿ëµÉ ¼ö ÀÖ´Ù.

Table 3.Identified kinases (active-site peptides) and corresponding relative quantitation determined using HR/AM MS data after inhibitor treatment. Kinase peptides measured using targeted multiplexed SIM are shown in bold.

Thermo Scientific ActivX Desthiobiotin-ATP¿Í Desthiobiotin-ADP Probe ±â¼ú°ú Q Exactive LC-MS ºÐ¼®Àº Àü¹ÝÀûÀΠȰ¼ºÈ¿¼Ò µ¿Á¤°ú ¾à¹° ¾ïÁ¦ ProfilingÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ÃÖÀûÀÇ WorkflowÀ» ¸¸µé¾î ³Â´Ù. ÀÌ¿Í °°ÀÌ »õ·Î¿î Ȱ¼º ºÎÀ§ Probe´Â ATP ÇÕ¼ºÈ¿¼ÒÀÇ ¾Æ°ú(Subfamily) °³Ã¼µéÀ» ƯÀÌÀûÀ¸·Î Àâ¾Æ³Â°í ¾ïÁ¦Á¦ ¼±Åüº Profiling°ú °áÇÕ Ä£Èµµ ÃøÁ¤¿¡ ´ëÇÑ È°¼ºÈ¿¼Ò MS °ËÃâÀ» Çâ»ó½ÃÄ×´Ù. HR/AM Full-scan MS¿Í msxSIM events¸¦ °áÇÕÇÑ °íÀ¯ÇÑ µ¥ÀÌÅÍ È¹µæ ¹æ¹ýÀº ½ºÆåÆ®·³ ¶óÀ̺귯¸®¸¦ ¸¸µé°í Target Ȱ¼ºÈ¿¼Ò Ȱ¼ºÀÚ¸® ÆéŸÀ̵带 ¸¸µå´Â µ¥ »ç¿ëµÉ ¼ö ÀÖ´Ù. Multiplexed SIM event´Â Background¿¡ ºñÇØ 7¹è ½ÅÈ£µéÀÌ Çâ»óµÈ Ȱ¼ºÈ¿¼Ò Ȱ¼ººÎÀ§ ÆéŸÀ̵尡 LC¿¡¼ µ¿½Ã¿¡ ºÐ¸®µÇ¾úÀ» ¶§¿¡µµ Cycle ½Ã°£À» ÃÖ´ëÈ Çϴµ¥ »ç¿ëµÇ¾ú´Ù. ÀÌ·¯ÇÑ Çâ»óµÈ Dynamic Range´Â IC50 °è»êÀ» À§ÇØ ÇÊ¿äÇÑ ³·Àº ³óµµÀÇ ÆéŸÀ̵å Á¤·® ºÐ¼®À» °¡´ÉÇÏ°Ô ÇÏ¿´´Ù. ³ª¾Æ°¡, ÅëÇÕµÈ ¼ÒÇÁÆ®¿þ¾î´Â ºÐ¼®½Ã°£À» ÁÙÀ̱â À§ÇØ ÀÚµ¿ÈµÈ ¹æ¹ý ±¸Ãà°ú µ¥ÀÌÅÍ ProcessingÀ» ´õ ¿ëÀÌÇÏ°Ô ÇÏ¿´´Ù. ÀÌ WorkflowÀº Q Exactive¿Í LC¿¡¼ 60ºÐÀÇ Gradient¸¦ »ç¿ëÇÔÀ¸·Î½á, 126°³°¡ ³Ñ´Â Ȱ¼ºÈ¿¼ÒÀÇ ¾ïÁ¦¿¡ ´ëÇÑ È°¼ººÎÀ§ ÆéŸÀ̵åÀÇ Á¤¼ººÐ¼®°ú Á¤·®ºÐ¼®À» Çϴµ¥ ¼º°øÀûÀ¸·Î »ç¿ëµÇ¾ú´Ù. |